Relay Therapeutics was able to report positive interim data from its phase 1 study, using RLY-2608 + fulvestrant. Learn more ...

Relay Therapeutics has up to 3.3 years cash runway, which, I believe, is sufficient to cover the RLY-2608's upcoming ...

Set to start in 2025, Relay Therapeutics is moving toward a pivotal study of experimental treatment RLY-2608 in heavily ...

A drug called ribociclib, currently used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer, a new study has ...

Receptor-mediated transcytosis (RMT) offers a promising pathway for transporting large molecules essential for brain function and treatment across the BBB. Results and discussion: One sdAb, defined as ...

Over the past year, this research has ... Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find new treatments for mesothelioma, a devastating cancer that has ...

This newest approval for amivantamab is the second approval in 6 months for the EGFR and MET bispecific antibody. Data from the MARIPOSA study (NCT04487080) support this newest approval, and ...

Beginning September 30, retailers must verify with photo identification the age of anyone younger than 30 who is trying to buy tobacco products—including electronic cigarettes—based on a final rule ...

This will be characterised by a transition towards more digitally enabled and decentralised continuous care pathways to better serve the evolving health needs of our community. Cardiovascular care, in ...